Prevalence and Risk Factors for Developing UTI in Women

Authors

  • O.A. Gaybullaev Basic Doctorate Student of Chair of Urology and Nephrology, Tashkent Institute of Advanced Medical Doctors. Author
  • A.A. Abdurizaev Docent of Chair of Urology and Nephrology, Tashkent Institute of Advanced Medical Doctors Author
  • A.A. Gaybullaev Head of Chair of Urology and Nephrology, Tashkent Institute of Advanced Medical Doctors Author

DOI:

https://doi.org/10.61841/cw5kac33

Keywords:

UTI in women, streptococci, Staphylococcus saprophyticus, Escherichia coli

Abstract

This article is written with the aim of presenting the results of a clinical trial, diagnosis and treatment of UTI in women. Characteristics of a common causative agent of uncomplicated UTI such as Escherichia coli, detected in about 80% of cases, and Staphylococcus saprophyticus, which causes the development of another 15% of cases, are given. In particular, the causes of complicated UTI were identified, the reason for their development is often bacteria that are extremely rare in uncomplicated forms, such as Pseudomonas aeruginosa and Proteus mirabilis, as well as group B streptococci.

 

Downloads

Download data is not yet available.

References

[1] Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653-660 DOI: 10,1038

Received: 10 Nov 2018 | Revised: 20 Dec 2018 | Accepted: 02 Jan 2019 8134

/ nrurol.2010.190

[2] Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002 Jul;113 (Suppl 1A):5–13.

[3] Loran O. B., Sinjakova L. A. Vospalitel'nye zabolevanija organov mochevoj sistemy. Aktual'nye voprosy.

— M.: MIA, 2008. URL: http://www.ncbi.nlm.nih.gov/pubmed/14404662.

[4] F.A. Akilov, B.M. Mamatkulov, U.A. Hudajbergenov, T.Ju. ugli Nuraliev, H.B. Hudojberdiev, M.K. Rahimov «Rasprostranennost' urologicheskih zabolevanij v regione Priaral'ja» jeksperimental'naja i klinicheskaja urologija #2 2012 www.ecuro.ru. - pp.12-17. URL: http://www.ncbi.nlm.nih.gov/pubmed/12113866

[5] Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002.

[6] Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am 1991 Mar;75(2):495–513. http://www.ncbi.nlm.nih.gov/pubmed/1996046.

[7] European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical.

[8] Bukhari S.S., Livsey S. Urinary Tract Infection: Presentation and Diagnosis // Med. Progress. — 2000. — N 1. — pp. 10–14.

[9] Hooton, TM, Besser, R, Foxman, B, et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39: 75-80.

[10] Hooton, TM, Stamm, WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11(3): 551-581.

[11] Abdurizaev A.A., Gajbullaeva O.A, Zhurnal medicina Uzbekistana. Vidovoj sostav mikroflory pacientov s infekciej mochevogo trakta, gospitalizirovannyh v jekstrennom porjadke. No.2, 2019. - p.65.

[12] Tandogdu Z, Wagenlehner FME. Global epidemiology of urinary tract infections. Curr Opin Infect Diseas.

[13] V.V. Rafal'skij, E.M. Moiseeva, 2018 UDK 616.62-002-036.22(470) ISSN 2308-6424 Jepidemiologija neoslozhnjonnyh vnebol'nichnyh infekcij mochevyvodjashhih putej v Rossijskoj Federacii. DOI 10.21886/2308-6424- 2018-6-2-30-37.

[14] Luiz Paulo José Marques, Juliana Timóteo Flores,Onofre de Oliveira Barros Junior, Giovana Breda Rodrigues, Carla de Medeiros Mourão, Rosa Maria Portella Moreira, Brazilian Journal of Infectious Diseases, 2012-09- 01, Tom 16, Vypusk 5, Copyright © 2012 Elsevier Editora Ltda. Epidemiological and clinical aspects of urinary tract infection in community-dwelling elderly women. 2012. – pp. 436-441.

Downloads

Published

30.09.2020

Issue

Vol. 24 No. 7 (2020): 24 (7) 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Gaybullaev, O., Abdurizaev, A., & Gaybullaev, A. (2020). Prevalence and Risk Factors for Developing UTI in Women. International Journal of Psychosocial Rehabilitation, 24(7), 8129-8135. https://doi.org/10.61841/cw5kac33